Comparative Research of Alzheimer's Disease Drugs

• Status: Terminated
• Trial end date: 2015-10-01
• Target enrollment: 0
• Participant gender: All

Summary

Conduct a comparative effectiveness clinical trial of medication treatment for behavioral symptoms of Alzheimer's disease in a group of real-world memory care clinics with enhanced access to the Indiana Network for Patient Care.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Indiana University
• Collaborator: Agency for Healthcare Research and Quality (AHRQ)
• Treatments: Donepezil; Galantamine; Rivastigmine

Criteria

Inclusion Criteria:

• older adults with a diagnosis of possible or probable Alzheimer's disease

• planning to initiate treatment with a cholinesterase inhibitor

• planning to continue care in the memory care practice

• participation by a family caregiver willing to complete the study outcome assessments

• access to a telephone

• ability to understand English-Language survey instruments

Exclusion Criteria:

• prior serious adverse event from the study medications